Registry of Outcomes of Dezawa MuseCells®
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 89
SponsorMuseCell Innovations Pte LTD
About this trial
The goal of this observational study is to learn about the long-term effects of Dezawa MuseCells to treat various diseases.
The Primary Goal: What is the short-term and long- term outcomes of Dezawa Musecells? Participants treated with Dezawa MuseCells as part of their regular medical care and will answer online survey questions about symptoms and clinical outcomes for 5 years.
Eligibility criteria
Qualifiers
Received Dezawa MuseCells® as Part of Routine Clinical Care
Patients ( and/or authorized representative) capable of providing informed consent and participating in long-term follow-up.
Willingness to Complete Online Survey Assessments
Participants must have reliable access to email or a mobile device and be willing to complete digital surveys at scheduled intervals over a 5-year period.
Disqualifiers
Not Receive Dezawa MuseCells®-Individuals who have not been treated with Dezawa MuseCells® or received a counterfeit/non-licensed product cannot be included.
Unable or Unwilling to Provide Informed Consent Includes individuals with cognitive impairment who lack a legally authorized representative willing to consent on their behalf.
Inability to Participate in Long-Term Digital Follow-Up
Concurrent Participation in an Interventional Clinical Trial Affecting Outcomes
Trial design
Treatments tested in this trial
- MuseCell Treatment
Treatment groups
5,000 Participants
are divided into 4 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov